Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston, Surgi-Vision in MRI-safe pact:

This article was originally published in Clinica

Executive Summary

In a bid to provide implantable cardiac device patients with safe access to MRI scans, Boston Scientific has entered a licensing and development agreement with Surgi-Vision. The agreement will see Boston gain access to Surgi-Vision's MRI-safe technology for use in implantable cardiac devices. The two companies also have an existing agreement to develop MRI-safe neuromodulation technology. Financial terms of the partnership were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046770

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel